1. Home
  2. TG vs PVLA Comparison

TG vs PVLA Comparison

Compare TG & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TG
  • PVLA
  • Stock Information
  • Founded
  • TG 1988
  • PVLA 2015
  • Country
  • TG United States
  • PVLA United States
  • Employees
  • TG N/A
  • PVLA N/A
  • Industry
  • TG Metal Fabrications
  • PVLA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TG Industrials
  • PVLA Health Care
  • Exchange
  • TG Nasdaq
  • PVLA Nasdaq
  • Market Cap
  • TG 301.0M
  • PVLA 253.2M
  • IPO Year
  • TG 1989
  • PVLA N/A
  • Fundamental
  • Price
  • TG $8.58
  • PVLA $22.30
  • Analyst Decision
  • TG
  • PVLA Strong Buy
  • Analyst Count
  • TG 0
  • PVLA 7
  • Target Price
  • TG N/A
  • PVLA $46.29
  • AVG Volume (30 Days)
  • TG 64.5K
  • PVLA 81.8K
  • Earning Date
  • TG 08-06-2025
  • PVLA 08-15-2025
  • Dividend Yield
  • TG N/A
  • PVLA N/A
  • EPS Growth
  • TG N/A
  • PVLA N/A
  • EPS
  • TG N/A
  • PVLA N/A
  • Revenue
  • TG $617,839,000.00
  • PVLA N/A
  • Revenue This Year
  • TG N/A
  • PVLA N/A
  • Revenue Next Year
  • TG N/A
  • PVLA N/A
  • P/E Ratio
  • TG N/A
  • PVLA N/A
  • Revenue Growth
  • TG 17.42
  • PVLA N/A
  • 52 Week Low
  • TG $4.31
  • PVLA $11.17
  • 52 Week High
  • TG $9.22
  • PVLA $29.27
  • Technical
  • Relative Strength Index (RSI)
  • TG 54.15
  • PVLA N/A
  • Support Level
  • TG $8.45
  • PVLA N/A
  • Resistance Level
  • TG $8.90
  • PVLA N/A
  • Average True Range (ATR)
  • TG 0.21
  • PVLA 0.00
  • MACD
  • TG -0.03
  • PVLA 0.00
  • Stochastic Oscillator
  • TG 44.17
  • PVLA 0.00

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: